STONKWHISPER
← Back to Intel
Insider ActivityRXRX

Borgeson Blake, Director at RECURSION PHARMACEUTICALS, INC., sold $106K of RXRX

Updated Jun 14, 2026
Borgeson Blake Director
RECURSION PHARMACEUTICALS, INC. · $RXRX
$106K Total Value
30,000 Shares Traded
$3.52 Price / Share
6,199,863 Shares Owned After
2026-05-07 Filing Date

Transaction Details

InsiderBorgeson Blake
TitleDirector
CompanyRECURSION PHARMACEUTICALS, INC.
TickerRXRX
Transaction TypeSale
Transaction Date2026-05-05
Shares Traded30,000
Price Per Share$3.52
Total Value$106K
Filed Date2026-05-07
Accession Number0001856094-26-000005

Ownership Context

Shares Owned After Transaction6,199,863
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001856094-26-000005

Other Insider Trades — RXRX

Other Trades by Borgeson Blake

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RXRX — RECURSION PHARMACEUTICALS, INC. →

Whisper Score — RXRX

29.16
Murmurs
Current Whisper Score

See full analysis for RXRX →

Track RXRX insider activity in real time on The Wire →

Get alerts when Borgeson Blake files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:13 UTC

Want real-time data? Access The Wire for live sentiment tracking.